ArticleThe Journal of infection2020
Risk factors for severe COVID-19: Evidence from 167 hospitalized patients in Anhui, China.
Abstract readLetterComment
In one paragraph
Article in The Journal of infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 12 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 12 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 12 syntheses or guidelines pooled it.
- The Impact of Neutrophil-Lymphocyte Count Ratio in COVID-19: A Systematic Review and Meta-Analysis.Journal of intensive care medicine · 2022Pooled it
- Cardiac biomarkers, cardiac injury, and comorbidities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.Immunity, inflammation and disease · 2021Pooled it
- A systematic meta-analysis of immune signatures in patients with COVID-19.Reviews in medical virology · 2021Pooled it
- Gastroenterology manifestations and COVID-19 outcomes: A meta-analysis of 25,252 cohorts among the first and second waves.Journal of medical virology · 2021Pooled it
- Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis.International journal of obesity (2005) · 2021Pooled it
- Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis.The American journal of emergency medicine · 2021Pooled it
- Association between markers of immune response at hospital admission and COVID-19 disease severity and mortality: A meta-analysis and meta-regression.Journal of medical virology · 2021Pooled it
- Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta-regression and decision tree analysis.Journal of medical virology · 2020Pooled it
- Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis.Archives of medical research · 2020Pooled it
- Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: A meta-analysis.Diabetes research and clinical practice · 2020Pooled it
- Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis.PloS one · 2020Pooled it
- Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis.Diabetes & metabolic syndromePooled it
- Levels of circulating kidney injury markers and IL-10 identify non-critically ill patients with COVID-19 at risk of death.JCI insight · 2026Trial
- Development and validation of a novel CD4Clinical and translational medicine · 2023Article
- Learning from real world data about combinatorial treatment selection for COVID-19.Frontiers in artificial intelligence · 2023Article
- Clinical manifestations of COVID-19 in patients with asthma, hypertension, and diabetes mellitus.Journal of medicine and life · 2022Article
- Influence of the Cumulative Incidence of COVID-19 Cases on the Mental Health of the Spanish Out-of-Hospital Professionals.Journal of clinical medicine · 2022Article
- A new screening tool for SARS-CoV-2 infection based on self-reported patient clinical characteristics: the COVBMC infectious diseases · 2022Article
- Epidemiological and clinical risk factors related to severe COVID-19 in Iran: a multi-center study.BMC infectious diseases · 2022Article
- The Association between TNF-α, IL-6, and Vitamin D Levels and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis.Pathogens (Basel, Switzerland) · 2022Review
Corrections and comments
- Comment on
Authors and funding
12 authors.
Yuan-Yuan WeiDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui Province, People's Republic of China.
Rui-Rui WangDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui Province, People's Republic of China; Department of Respiratory and Critical Care Medicine, the Second People's Hospital of Fuyang City, Yingzhou west Road 1088, Fuyang, Anhui 236015, People's Republic of China.
Da-Wei ZhangDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui Province, People's Republic of China.
You-Hui TuDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui Province, People's Republic of China.
Chang-Shan ChenDepartment of Respiratory and Critical Care Medicine, the First People's Hospital of Chuzhou City, Anhui Province, People's Republic of China.
Shuang JiDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui Province, People's Republic of China.
Chun-Xi LiDepartment of Respiratory and Critical Care Medicine, the Second People's Hospital of Fuyang City, Yingzhou west Road 1088, Fuyang, Anhui 236015, People's Republic of China.
Xiu-Yong LiDepartment of Respiratory and Critical Care Medicine, the Second People's Hospital of Fuyang City, Yingzhou west Road 1088, Fuyang, Anhui 236015, People's Republic of China.
Meng-Xi ZhouDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui Province, People's Republic of China.
Wen-Sheng CaoDepartment of Infectious Diseases, the Second People's Hospital of Chuzhou City, Anhui Province, People's Republic of China.
Ming-Feng HanDepartment of Respiratory and Critical Care Medicine, the Second People's Hospital of Fuyang City, Yingzhou west Road 1088, Fuyang, Anhui 236015, People's Republic of China. Electronic address: fyhmf@163.com.
Guang-He FeiDepartment of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui Province, People's Republic of China. Electronic address: guanghefei@126.com.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
CoronavirusBetacoronavirusChinaCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralRisk FactorsSARS-CoV-2
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.